Results 181 to 190 of about 6,266 (218)
Some of the next articles are maybe not open access.

Management of dyskinesia in anti-NMDAR encephalitis with tramadol

Clinical Neurology and Neurosurgery, 2016
Anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephaliis is a fairly new diagnosis that was discovered in 2005 after our young women developed ovarian teratomas with psychiatric ymptoms, seizures, altered mental status, and eventual central ypoventilation [1]. It is an autoimmune encephalitis of variable araneoplastic origin caused by IgG antibodies
Ali Seifi
exaly   +3 more sources

Anti-NMDAR Encephalitis

The Neurodiagnostic Journal, 2016
Anti-N-methyl-D-aspartate receptor encephalitis is a newly described disease process. Patients are generally young females who present with psychiatric symptoms and progress to have seizures, abnormal movements, and. autonomic instability. Diagnosis is made based on serum and cerebrospinal fluid results, However, a characteristic EEG pattern described ...
Linda J, Kelly, Vicki L, Sexton
openaire   +2 more sources

Anti-NMDAR autoimmune encephalitis

Brain and Development, 2014
The N-methyl-D-aspartate receptor (NMDAR) is involved in normal physiological and pathological states in the brain. Anti-NMDAR encephalitis is characterized by memory deficits, seizures, confusion, and psychological disturbances in males and females of all ages.
Kazushi, Miya   +2 more
openaire   +2 more sources

Claustrum hyperintensity as a marker of anti-NMDAR encephalitis

Postgraduate Medical Journal, 2021
A young adult male patient presented with subacute onset, rapidly progressive cognitive impairment and refractory seizures and was diagnosed as definite anti N-methyl D-aspartate receptor (anti-NMDAR) antibody encephalitis as per criteria by Graus et al. (2016), following detection of culprit autoantibodies in serum.1 MRI of brain revealed bilateral T2-
Amlan Kusum Datta   +4 more
openaire   +2 more sources

Analysis of relapses in anti-NMDAR encephalitis

Neurology, 2011
The clinical characteristics of patients with relapsing anti-NMDA receptor (NMDAR) encephalitis are not well-defined. In this study, we report the clinical profile and outcome of relapses in a series of anti-NMDAR encephalitis.We did a retrospective review of relapses that occurred in 25 patients with anti-NMDAR encephalitis.
I, Gabilondo   +12 more
openaire   +2 more sources

HSV encephalitis triggered anti-NMDAR encephalitis: a case report

Neurological Sciences, 2021
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis (AE) is a common cause of nonviral infectious encephalitis, which can be triggered by herpes simplex virus infection. Previous studies have shown that approximately 27% of herpes simplex encephalitis (HSE) patients produce anti-NMDAR antibodies within 3 months. Immunotherapy is recommended in this
Shiyu Hu   +5 more
openaire   +2 more sources

Anti–NMDAR encephalitis complicating pregnancy

Practical Neurology, 2018
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis was first reported in 2005 in four patients with ovarian teratomas; there have been many further cases reported since the antigen for the NMDAR antibody was confirmed in 2007. Patients characteristically have a well-defined set of features, characterised by psychiatric disturbance, seizures and ...
Sabrina, Kalam   +3 more
openaire   +2 more sources

Anti-NMDAR encephalitis mimicking HaNDL syndrome

Cephalalgia, 2014
Background Anti-NMDA receptor encephalitis typically manifests as severe multistage neuropsychiatric syndrome. However, milder or incomplete forms of the disorder have been recognised. Here, we report on a patient with anti-NMDA receptor encephalitis with a clinical phenotype mimicking the syndrome of headache ...
Carsten, Finke   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy